648 related articles for article (PubMed ID: 22520940)
1. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.
Chaudhary R; Likidlilid A; Peerapatdit T; Tresukosol D; Srisuma S; Ratanamaneechat S; Sriratanasathavorn C
Cardiovasc Diabetol; 2012 Apr; 11():36. PubMed ID: 22520940
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
El-Lebedy D; Raslan HM; Mohammed AM
Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E E3/E4 genotype is associated with an increased risk of type 2 diabetes mellitus complicated with coronary artery disease.
Chen W; Li B; Wang H; Wei G; Chen K; Wang W; Wang S; Liu Y
BMC Cardiovasc Disord; 2024 Mar; 24(1):160. PubMed ID: 38491412
[TBL] [Abstract][Full Text] [Related]
4. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
Duman BS; Oztürk M; Yilmazer S; Hatemi H
Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
[TBL] [Abstract][Full Text] [Related]
6. Butyrylcholinesterase K variant and the APOE-epsilon 4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients.
Vaisi-Raygani A; Rahimi Z; Tavilani H; Pourmotabbed T
Mol Biol Rep; 2010 Apr; 37(4):2083-91. PubMed ID: 19685167
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the Association of Apolipoprotein E Gene Polymorphisms With Type 2 Diabetes Mellitus and Coronary Artery Disease.
Wu L; Zhang Y; Zhao H; Rong G; Huang P; Wang F; Xu T
Front Endocrinol (Lausanne); 2022; 13():838547. PubMed ID: 35211094
[TBL] [Abstract][Full Text] [Related]
8. Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease.
Souza DR; Nakachima L; Biagioni RB; Nakazone MA; Pinhel MA; Trindade DM; Mafra VT; Tácito LH; Martin JF; Pinheiro Júnior S; Brandão AC
Braz J Med Biol Res; 2007 Feb; 40(2):189-97. PubMed ID: 17273655
[TBL] [Abstract][Full Text] [Related]
9. ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population.
Afroze D; Yousuf A; Tramboo NA; Shah ZA; Ahmad A
Clin Exp Med; 2016 Nov; 16(4):551-556. PubMed ID: 26409839
[TBL] [Abstract][Full Text] [Related]
10. APOE gene ɛ4 allele (388C-526C) effects on serum lipids and risk of coronary artery disease in southern Chinese Hakka population.
Liu Q; Wu H; Yu Z; Huang Q; Zhong Z
J Clin Lab Anal; 2021 Sep; 35(9):e23925. PubMed ID: 34313350
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes.
Liu S; Liu J; Weng R; Gu X; Zhong Z
BMC Cardiovasc Disord; 2019 Sep; 19(1):213. PubMed ID: 31521122
[TBL] [Abstract][Full Text] [Related]
12. Effect of apolipoprotein E polymorphism and apolipoprotein A-1 gene promoter polymorphism on lipid parameters and premature coronary artery disease.
Petrovic D; Zorc M; Peterlin B
Folia Biol (Praha); 2000; 46(5):181-5. PubMed ID: 11055796
[TBL] [Abstract][Full Text] [Related]
13. Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Hakka postmenopausal women in southern China.
Hou J; Deng Q; Guo X; Deng X; Zhong W; Zhong Z
Lipids Health Dis; 2020 Jun; 19(1):139. PubMed ID: 32546237
[TBL] [Abstract][Full Text] [Related]
14. A Case-Control Study of the Association of the Polymorphisms of MTHFR and APOE with Risk Factors and the Severity of Coronary Artery Disease.
Long Y; Zhao XT; Liu C; Sun YY; Ma YT; Liu XY; Liu JX
Cardiology; 2019; 142(3):149-157. PubMed ID: 31163415
[TBL] [Abstract][Full Text] [Related]
15. Association of APOE and CETP TaqIB Polymorphisms with Type 2 Diabetes Mellitus.
Srirojnopkun C; Kietrungwilaikul K; Boonsong K; Thongpoonkaew J; Jeenduang N
Arch Med Res; 2018 Oct; 49(7):479-485. PubMed ID: 30853126
[TBL] [Abstract][Full Text] [Related]
16. Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus.
Ozuynuk AS; Erkan AF; Dogan N; Ekici B; Erginel-Unaltuna N; Kurmus O; Coban N
J Diabetes Complications; 2022 Jan; 36(1):108078. PubMed ID: 34686405
[TBL] [Abstract][Full Text] [Related]
17. PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
Wan J; Xiong S; Chao S; Xiao J; Ma Y; Wang J; Roy S
Cardiovasc Diabetol; 2010 Mar; 9():13. PubMed ID: 20334678
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.
Roussos L; Ekström U; Ehle PN; Oqvist B; Floren CH
Scand J Urol Nephrol; 2004; 38(6):504-10. PubMed ID: 15841787
[TBL] [Abstract][Full Text] [Related]
19. [The apolipoprotein E-CI-CII gene cluster polymorphisms and coronary artery disease].
Wang C; Zhou X; Zheng F; Han D; Shi Q; Liu F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):164-8. PubMed ID: 15793777
[TBL] [Abstract][Full Text] [Related]
20. Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India.
Biswas S; Ghoshal PK; Halder B; Ganguly K; DasBiswas A; Mandal N
Indian Heart J; 2013 Dec; 65(6):658-65. PubMed ID: 24407534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
